成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 183322-18-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 183322-18-1
Chemical Structure| 183322-18-1
Structure of 183322-18-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 183322-18-1 ]

Related Doc. of [ 183322-18-1 ]

Alternatived Products of [ 183322-18-1 ]
Product Citations

Product Details of [ 183322-18-1 ]

CAS No. :183322-18-1 MDL No. :MFCD09751265
Formula : C14H17ClN2O4 Boiling Point : No data available
Linear Structure Formula :- InChI Key :ZPJLDMNVDPGZIU-UHFFFAOYSA-N
M.W : 312.75 Pubchem ID :11289942
Synonyms :

Calculated chemistry of [ 183322-18-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.43
Num. rotatable bonds : 8
Num. H-bond acceptors : 6.0
Num. H-bond donors : 0.0
Molar Refractivity : 78.93
TPSA : 62.7 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.5
Log Po/w (XLOGP3) : 2.15
Log Po/w (WLOGP) : 2.33
Log Po/w (MLOGP) : 0.42
Log Po/w (SILICOS-IT) : 3.08
Consensus Log Po/w : 2.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.96
Solubility : 0.345 mg/ml ; 0.0011 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.249 mg/ml ; 0.000796 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.28
Solubility : 0.00163 mg/ml ; 0.00000521 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.44

Safety of [ 183322-18-1 ]

Signal Word:Warning Class:
Precautionary Statements:P280-P305+P351+P338-P310 UN#:
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 183322-18-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 183322-18-1 ]

[ 183322-18-1 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 34272-64-5 ]
  • [ 183322-18-1 ]
  • [ 1370256-52-2 ]
  • 2
  • [ 90924-12-2 ]
  • [ 183322-18-1 ]
  • [ 1459184-09-8 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In isopropyl alcohol; at 20 - 60℃; [0039] 0.3 g (1 mmol) of (6,7-bis(2-methoxyethoxy))-4-chloro-quinazoline was dissolved in 5 mL dry isopropanol.Under stirring, a solution of 0.175 g (1 mmol) of 5-hydroxy3-phenyl-isoxazole in 5 mL of isopropanol was slowly addeddropwise to the reaction system, followed by the addition 0.101g (1 mmol) of freshly distilled triethylamine. After thesystem was stirred at room temperature for 30 min, the reaction was hold at 60C. After the completion of the reactionmonitored by TLC, the reaction solution was concentrated under vacuum. The residue was directely seperated by columnchromatography (Vpetroleum ether : Vethyl acetate = 5:1-2:1) to give the target compound of (6,7-bis(2-methoxyethoxy))-4-((3-(4-methylphenyl)-isoxazol-5-yl))-methoxy-)-quinazoline (i.e. Q-15 in the following Table). The other compoundswere synthesized according to the synthetic process of (6,7-bis(2-methoxyethoxy))-4-((3-(4-methylphenyl)-isoxazol-5-yl))-methoxy-)-quinazoline. The structures were characterized by analytic methods such as IR, 1H NMR, ESI-MS, etc.The physical constants and spectral data of preferred compounds were indicated in the form of table.
With triethylamine; In isopropyl alcohol; at 20℃; for 0.5h; 0.3 g (1 mmol) of (6,7-bis(2-methoxyethoxy))-4- chioro-quinazoline was dissolved in 5 mL dry isopropanol. Under stirring, a solution of 0.175 g (1 mmol) of 5-hydroxy3- phenyl-isoxazole in 5 mL of isopropanol was slowly added dropwise to the reaction system, followed by the addition 0.101 g (1 mmol) of freshly distilled triethylamine. After the system was stirred at room temperature for 30 mm, the reaction was hold at 60. After the completion of the reaction monitored by TLC, the reaction solution was concentrated under vacuum. The residue was directly separated by colunm chromatography (Vpetroleum ether: Vethyl acetate5: 1-2:1) to give the target compound of (6,7-bis(2-methoxyethoxy))- 4-((3-(4-methylphenyl)-isoxazol-5-yl))-methoxy-)-quinazo- line (i.e. Q-15 in the following Table). The other compounds were synthesized according to the synthetic process of (6,7- bis(2-methoxyethoxy))-4-((3-(4-methylphenyl)-isoxazol-5- yl))-methoxy-)-quinazoline. The structures were characterized by analytic methods such as IR, ?H NMR, ESI-MS, etc. The physical constants and spectral data of preferred compounds were indicated in the form of table.
With triethylamine; In isopropyl alcohol; for 0.5h;Heating; The 0.3g (1mmol) of [6,7-bis(methoxyethoxy)]-4-chloroquinazoline is dissolved in 5 ml dry isopropanol, mixing with 0.175g (1mmol) 5-hydroxy methyl-3-phenyl-isoxazole 5 ml isopropanol solution is slowly dropped into the reaction system, then add 0.101 g (1mmol) of freshly distilled triethylamine, system stirring at room temperature for 30 min then, 60 C reaction, TLC detection after finishing the reaction, the reaction solution in vacuo, the residue is directly column separation V (petroleum ether): V (ethyl acetate) = 5:1-2:1) to obtain the target compound [6,7-bis(methoxyethoxy)]-4-[3-(4-methylphenyl)isoxazol-5-yl]methoxy}quinazoline (Q-15 in the following table). In accordance with the remaining compound [6,7-bis(2-methoxyethoxy)]-4-[3-(4-methylphenyl)isoxazol-5-yl]methoxy}quinazoline the synthetic course of the synthesis. Its structure through IR, 1 HNMR, ESI-MS analyzing for the characterization. The preferred compound Physical constants and spectral data in order to list a description of the form of:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 183322-18-1 ]

Erlotinib Related Intermediates

Chemical Structure| 236750-65-5

[ 236750-65-5 ]

4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile

Chemical Structure| 80407-64-3

[ 80407-64-3 ]

3,4-Bis(2-methoxyethoxy)benzaldehyde

Chemical Structure| 16064-15-6

[ 16064-15-6 ]

6,7-Dihydroxyquinazolin-4(3H)-one

Chemical Structure| 950596-58-4

[ 950596-58-4 ]

2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile

Chemical Structure| 179688-29-0

[ 179688-29-0 ]

6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one

; ;